Celldex to Report Second Quarter 2018 Financial Results and Host Corporate Update Call
August 02 2018 - 8:01AM
Celldex Therapeutics, Inc. (Nasdaq:CLDX) will release second
quarter 2018 financial results on Wednesday, August 8, 2018 after
the U.S. financial markets close. Celldex executives will host a
conference call at 4:30 p.m. EDT on the same day to review the
second quarter 2018 financial results and to provide an update on
key research and development and business objectives for the
remainder of 2018.
The conference call and presentation will be webcast live over
the Internet and can be accessed by going to the "Events &
Presentations" page under the "Investors & Media" section of
the Celldex Therapeutics website at www.celldex.com. The call can
also be accessed by dialing (866) 743-9666 (within the United
States) or (760) 298-5103 (outside the United States). The passcode
is 4768019.
A replay of the call will be available approximately two hours
after the live call concludes through August 15, 2018. To access
the replay, dial (855) 859-2056 (within the United States) or (404)
537-3406 (outside the United States). The passcode is 4768019. The
webcast will also be archived on the Company's website.
About Celldex Therapeutics, Inc.
Celldex is developing targeted therapeutics to address
devastating diseases for which available treatments are inadequate.
Our pipeline includes immunotherapies and other targeted biologics
derived from a broad set of complementary technologies which have
the ability to engage the human immune system and/or directly
inhibit tumors to treat specific types of cancer or other diseases.
Visit www.celldex.com.
Company ContactSarah CavanaughSenior Vice
President, Corporate Affairs & AdministrationCelldex
Therapeutics, Inc.(781) 433-3161scavanaugh@celldex.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Sep 2023 to Sep 2024